UBS Group’s Taro Pharmaceutical Industries Ltd. TARO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-31,317
| Closed | -$1.33M | – | 8976 |
|
|
2024
Q1 | $1.33M | Sell |
31,317
-5,587
| -15% | -$237K | ﹤0.01% | 3340 |
|
|
2023
Q4 | $1.54M | Sell |
36,904
-17,271
| -32% | -$722K | ﹤0.01% | 3077 |
|
|
2023
Q3 | $2.04M | Buy |
54,175
+19,588
| +57% | +$739K | ﹤0.01% | 2532 |
|
|
2023
Q2 | $1.31M | Buy |
34,587
+33,655
| +3,611% | +$1.28M | ﹤0.01% | 3071 |
|
|
2023
Q1 | $22.7K | Buy |
932
+381
| +69% | +$9.27K | ﹤0.01% | 5897 |
|
|
2022
Q4 | $16K | Buy |
551
+451
| +451% | +$13.1K | ﹤0.01% | 6748 |
|
|
2022
Q3 | $3K | Sell |
100
-825
| -89% | -$24.8K | ﹤0.01% | 8511 |
|
|
2022
Q2 | $34K | Buy |
925
+386
| +72% | +$14.2K | ﹤0.01% | 5255 |
|
|
2022
Q1 | $24K | Sell |
539
-236
| -30% | -$10.5K | ﹤0.01% | 6221 |
|
|
2021
Q4 | $39K | Buy |
775
+279
| +56% | +$14K | ﹤0.01% | 6059 |
|
|
2021
Q3 | $32K | Sell |
496
-4,135
| -89% | -$267K | ﹤0.01% | 5581 |
|
|
2021
Q2 | $333K | Sell |
4,631
-761
| -14% | -$54.7K | ﹤0.01% | 4014 |
|
|
2021
Q1 | $398K | Sell |
5,392
-383
| -7% | -$28.3K | ﹤0.01% | 4089 |
|
|
2020
Q4 | $424K | Sell |
5,775
-62,385
| -92% | -$4.58M | ﹤0.01% | 3789 |
|
|
2020
Q3 | $3.74M | Buy |
68,160
+21,655
| +47% | +$1.19M | ﹤0.01% | 1929 |
|
|
2020
Q2 | $3.09M | Buy |
46,505
+42,585
| +1,086% | +$2.83M | ﹤0.01% | 1949 |
|
|
2020
Q1 | $240K | Buy |
3,920
+1,350
| +53% | +$82.7K | ﹤0.01% | 3764 |
|
|
2019
Q4 | $226K | Sell |
2,570
-2,215
| -46% | -$195K | ﹤0.01% | 4532 |
|
|
2019
Q3 | $361K | Sell |
4,785
-7,803
| -62% | -$589K | ﹤0.01% | 3956 |
|
|
2019
Q2 | $1.08M | Buy |
12,588
+10,794
| +602% | +$923K | ﹤0.01% | 3010 |
|
|
2019
Q1 | $194K | Buy |
1,794
+203
| +13% | +$22K | ﹤0.01% | 3860 |
|
|
2018
Q4 | $135K | Buy |
1,591
+643
| +68% | +$54.6K | ﹤0.01% | 4418 |
|
|
2018
Q3 | $94K | Sell |
948
-970
| -51% | -$96.2K | ﹤0.01% | 4776 |
|
|
2018
Q2 | $222K | Sell |
1,918
-4,008
| -68% | -$464K | ﹤0.01% | 4025 |
|
|
2018
Q1 | $585K | Sell |
5,926
-276
| -4% | -$27.2K | ﹤0.01% | 3378 |
|
|
2017
Q4 | $650K | Sell |
6,202
-2,715
| -30% | -$285K | ﹤0.01% | 3286 |
|
|
2017
Q3 | $1.01M | Buy |
8,917
+1,953
| +28% | +$220K | ﹤0.01% | 2997 |
|
|
2017
Q2 | $780K | Sell |
6,964
-11,653
| -63% | -$1.31M | ﹤0.01% | 3078 |
|
|
2017
Q1 | $2.17M | Sell |
18,617
-2,259
| -11% | -$264K | ﹤0.01% | 2301 |
|
|
2016
Q4 | $2.2M | Buy |
20,876
+3,599
| +21% | +$379K | ﹤0.01% | 2218 |
|
|
2016
Q3 | $1.91M | Buy |
17,277
+10,048
| +139% | +$1.11M | ﹤0.01% | 2260 |
|
|
2016
Q2 | $1.05M | Buy |
7,229
+5,092
| +238% | +$742K | ﹤0.01% | 2662 |
|
|
2016
Q1 | $306K | Sell |
2,137
-6,676
| -76% | -$956K | ﹤0.01% | 3485 |
|
|
2015
Q4 | $1.36M | Sell |
8,813
-2,084
| -19% | -$322K | ﹤0.01% | 2475 |
|
|
2015
Q3 | $1.56M | Buy |
10,897
+4,086
| +60% | +$584K | ﹤0.01% | 2324 |
|
|
2015
Q2 | $979K | Sell |
6,811
-10,727
| -61% | -$1.54M | ﹤0.01% | 2820 |
|
|
2015
Q1 | $2.47M | Buy |
17,538
+9,643
| +122% | +$1.36M | ﹤0.01% | 2140 |
|
|
2014
Q4 | $1.17M | Buy |
+7,895
| New | +$1.17M | ﹤0.01% | 2636 |
|